Literature DB >> 24871208

[Radiotherapy for solitary plasmacytoma and multiple myeloma].

M C Schmaus1, D Neuhof.   

Abstract

Solitary plasmacytoma and multiple myeloma require a differentiated radiotherapy. The irradiation for plasmacytoma with an adequate total dose (medullary 40-50 Gy or extramedullary 50-60 Gy) leads to a high degree of local control with a low rate of side effects. In cases of multiple myeloma radiotherapy will achieve effective palliation, both in terms of recalcification as well as reduction of neurological symptoms and analgesia. In terms of analgesia the rule is the higher the single dose fraction the faster the reduction of pain. As part of a conditioning treatment prior to stem cell transplantation radiotherapy contributes to the establishment of a graft versus myeloma effect (GVM).

Entities:  

Mesh:

Year:  2014        PMID: 24871208     DOI: 10.1007/s00117-013-2630-2

Source DB:  PubMed          Journal:  Radiologe        ISSN: 0033-832X            Impact factor:   0.635


  17 in total

1.  Radiotherapy for solitary extramedullary plasmacytoma in the head-and-neck region: A dose greater than 45 Gy to the target volume improves the local control.

Authors:  Laetitia Tournier-Rangeard; Michel Lapeyre; Pierre Graff-Caillaud; Alice Mege; Gilles Dolivet; Bruno Toussaint; Claire Charra-Brunaud; Sylvette Hoffstetter; Christian Marchal; Didier Peiffert
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-12-15       Impact factor: 7.038

2.  Radiotherapy in the treatment of solitary plasmacytoma.

Authors:  R Jyothirmayi; V P Gangadharan; M K Nair; B Rajan
Journal:  Br J Radiol       Date:  1997-05       Impact factor: 3.039

3.  The role of radiation therapy in the treatment of solitary plasmacytomas.

Authors:  N A Mayr; B C Wen; D H Hussey; C P Burns; J J Staples; J F Doornbos; A P Vigliotti
Journal:  Radiother Oncol       Date:  1990-04       Impact factor: 6.280

4.  Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.

Authors:  S Gerull; M Goerner; A Benner; U Hegenbart; U Klein; H Schaefer; H Goldschmidt; A D Ho
Journal:  Bone Marrow Transplant       Date:  2005-12       Impact factor: 5.483

5.  Clinical course of solitary extramedullary plasmacytoma.

Authors:  R H Liebross; C S Ha; J D Cox; D Weber; K Delasalle; R Alexanian
Journal:  Radiother Oncol       Date:  1999-09       Impact factor: 6.280

6.  Radiotherapy in the management of solitary extramedullary plasmacytoma.

Authors:  M W Chao; P Gibbs; A Wirth; G Quong; M J Guiney; K H Liew
Journal:  Intern Med J       Date:  2005-04       Impact factor: 2.048

7.  [Role of radiotherapy in the treatment of multiple myeloma].

Authors:  S Mose; D Pfitzner; A Rahn; C Nierhoff; M Schiemann; H D Böttcher
Journal:  Strahlenther Onkol       Date:  2000-11       Impact factor: 3.621

8.  Persistence of myeloma protein for more than one year after radiotherapy is an adverse prognostic factor in solitary plasmacytoma of bone.

Authors:  Richard B Wilder; Chul S Ha; James D Cox; Donna Weber; Kay Delasalle; Raymond Alexanian
Journal:  Cancer       Date:  2002-03-01       Impact factor: 6.860

9.  Outcomes and patterns of failure in solitary plasmacytoma: a multicenter Rare Cancer Network study of 258 patients.

Authors:  Mahmut Ozsahin; Richard W Tsang; Philip Poortmans; Yazid Belkacémi; Michel Bolla; Fazilet Oner Dinçbas; Christine Landmann; Bernard Castelain; Jeroen Buijsen; Jürgen Curschmann; Sidney P Kadish; Anna Kowalczyk; Yavuz Anacak; Josef Hammer; Tan D Nguyen; Gabriela Studer; Rachel Cooper; Meriç Sengöz; Luciano Scandolaro; Abderrahim Zouhair
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-10-17       Impact factor: 7.038

10.  Radiotherapy for extramedullary plasmacytoma of the head and neck.

Authors:  Kimberly M Creach; Robert L Foote; Michelle A Neben-Wittich; Robert A Kyle
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-15       Impact factor: 7.038

View more
  1 in total

Review 1.  Solitary extramedullary plasmacytoma of the adrenal gland: a rare case report with review of the literature.

Authors:  Dehong Cao; Li Li; Liangren Liu; Wei Xiao; Xin He; Zhuang Tang; Jiuhong Yuan; Xiang Li; Wei Qiang
Journal:  Int J Clin Exp Pathol       Date:  2014-12-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.